[Federal Register Volume 72, Number 56 (Friday, March 23, 2007)]
[Notices]
[Page 13825]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-5391]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on December 7, 2006, Sigma 
Aldrich Research, Biochemicals, Inc., 1-3 Strathmore Road, Natick, 
Massachusetts 01760, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed in schedule I:

 
------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Psilocybin (7437)..........................  I
5-Methoxy-N,N-diisopropyltryptamine (7439).  I
------------------------------------------------------------------------

    The company plans on manufacturing reference standards for research 
purposes only.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA >Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than May 22, 2007.

    Dated: March 9, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-5391 Filed 3-22-07; 8:45 am]
BILLING CODE 4410-09-P